Incremental Burden of Pulmonary Hypertension Among Patients With Interstitial Lung Disease in the Real-World Setting
Healthcare Resource Utilization in Refractory MACLD: Comparison of an Amikacin Liposome Inhalation Suspension (ALIS) Cohort with a Non-ALIS Cohort
Persistent Use of Amikacin Liposome Inhalation Suspension Associated with Lower Risk of Hospitalizations and Emergency Room Visits in Refractory Mycobacterium Avium Complex Lung Disease
Longer use of Amikacin Liposomal Inhalation Suspension During First 12 Months Associated with Lower Risk of Hospitalizations and Emergency Room Visits: A Claims Analysis
Severe Exacerbations in Patients Following Improved Adherence to Inhaled Corticosteroid-Containing Asthma Maintenance Medications Versus Not: A US Claim-Based Study
Impact Of Timing Of Nontuberculous Mycobacterial Lung Disease Antibiotic Initiation On Hospitalizations And Outpatient Visits In Japan
Longer Use of Amikacin Liposomal Inhalation Suspension During First 12 Months Associated with Lower Risk of Hospitalizations and Emergency Room Visits: A Claims Analysis
